Timber Hill’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-23,116
Closed -$419K 2346
2016
Q3
$481K Buy
23,116
+8,670
+60% +$215K ﹤0.01% 1499
2016
Q2
$388K Buy
14,446
+6,084
+73% +$167K ﹤0.01% 1697
2016
Q1
$227K Buy
+8,362
New +$224K ﹤0.01% 1899
2015
Q4
Sell
-16,346
Closed -$452K 2400
2015
Q3
$443K Buy
+16,346
New +$463K ﹤0.01% 1855
2014
Q2
Sell
-43,030
Closed -$950K 2893
2014
Q1
$982K Buy
+43,030
New +$917K ﹤0.01% 1624
2013
Q4
Sell
-202,090
Closed -$3.52M 3136
2013
Q3
$3.42M Buy
202,090
+176,170
+680% +$2.96M 0.01% 1090
2013
Q2
$402K Buy
+25,920
New +$431K ﹤0.01% 2633

Other funds holding NVO

Timber Hill's NVO Position: Q4 2016 in Review

Timber Hill sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 23,116 shares — an estimated $419K sold.

Timber Hill first reported a position in NVO in Q2 2013 and held it in 7 quarters. The position peaked at $3.42M in Q3 2013. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Timber Hill reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • Timber Hill sold 23,116 Novo Nordisk shares in Q4 2016, an estimated $419K.
  • Timber Hill first reported a position in Novo Nordisk in Q2 2013 and held it in 7 quarters.
  • Timber Hill's Novo Nordisk position peaked at $3.42M in Q3 2013.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Timber Hill's 13F filing for Q4 2016, filed 8 Feb 2017.